Meloxicam | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Meloxicam
U.S. EXCLUSIVITIES

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Meloxicam

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

56 API Suppliers, 22 USDMF, 15 CEP/COS, 7 JDMF, 15 EU WC, 26 KDMF, 20 NDC API, 34 Listed Suppliers, $ API Reference Price

56 API Suppliers
22 USDMF
15 CEP/COS
7 JDMF
15 EU WC
26 KDMF
20 NDC API
34 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

47 Drugs in Development

47 Drugs in Development

INTERMEDIATES

13 Intermediates Suppliers

13 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

320 FDF Dossiers, 62 FDA Orange Book, 69 Europe, 34 Canada, 32 Australia, 44 South Africa, 79 Listed Dossiers

320 FDF Dossiers
62 FDA Orange Book
69 Europe
34 Canada
32 Australia
44 South Africa
79 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 15MG, TABLET;ORAL - 7.5MG, SOLUTION;INTRAVENOUS - 30MG/ML (30MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION;ORAL - 7.5MG/5ML

TABLET;ORAL - 15MG
TABLET;ORAL - 7.5MG
SOLUTION;INTRAVENOUS - 30MG/ML (30MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SUSPENSION;ORAL - 7.5MG/5ML

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 3 Rochem International Inc, 8 SPI Pharma, 11 DKSH, 2 Jai Radhe Sales, 6 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 15 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 7 Actylis, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 20 BASF, 7 DFE Pharma, 7 Gangwal Chemicals, 2 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 26 Kerry, 3 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Novo Excipients, 5 Pharmatrans-Sanaq, 6 Pluviaendo, 5 Prachin Chemical, 1 Qualicaps, 27 Roquette, 1 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

80 Fillers, Diluents & Binders, 43 Disintegrants & Superdisintegrants, 41 Direct Compression, 26 Granulation, 25 Thickeners and Stabilizers, 21 Lubricants & Glidants, 19 Co-Processed Excipients, 17 Coating Systems & Additives, 16 Taste Masking, 14 Chewable & Orodispersible Aids, 13 Controlled & Modified Release, 12 Film Formers & Plasticizers, 10 Solubilizers, 9 Parenteral, 8 Empty Capsules, 7 Topical, 5 Rheology Modifiers, 4 Emulsifying Agents, 3 API Stability Enhancers, 2 Coloring Agents, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

80 Fillers, Diluents & Binders
43 Disintegrants & Superdisintegrants
41 Direct Compression
26 Granulation
25 Thickeners and Stabilizers
21 Lubricants & Glidants
19 Co-Processed Excipients
17 Coating Systems & Additives
16 Taste Masking
14 Chewable & Orodispersible Aids
13 Controlled & Modified Release
12 Film Formers & Plasticizers
10 Solubilizers
9 Parenteral
8 Empty Capsules
7 Topical
5 Rheology Modifiers
4 Emulsifying Agents
3 API Stability Enhancers
2 Coloring Agents
1 Soft Gelatin
1 Surfactant & Foaming Agents

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 46 NEWS #PharmaBuzz

4 DATA COMPILATION #PharmaFlow
46 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 57 Finished Drug Prices, 1 Annual Reports

3 US Medicaid Prescriptions
57 Finished Drug Prices
1 Annual Reports

MARKET PLACE

33 APIs, 2 FDF Dossiers, 1 Intermediates

33 APIs
2 FDF Dossiers
1 Intermediates

PATENTS & EXCLUSIVITIES

81 US Patents, 8 US Exclusivities, 2 Health Canada Patents

81 US Patents
8 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 6 USP, 6 Others

5 EDQM
6 USP
6 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 96 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

8 All

01 8HERON THERAPS INC

filter Product Reset all filters

8 All

01 8BUPIVACAINE; MELOXICAM

filter Exclusivity Expiration Date Reset all filters

8 All

01 42024-05-12

02 42027-01-23

filter Exclusivity Code Reset all filters

8 All

01 4I-933

02 4NP

Product Main Page

HERON THERAPS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUPIVACAINE; MELOXICAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-933

Exclusivity Expiration Date

2027-01-23

Application Number

211988

Product Number

2

Exclusivity Details

01

HERON THERAPS INC

BUPIVACAINE; MELOXICAM

CPhI India 2024

Not Confirmed

HERON THERAPS INC

U.S.A

CPhI India 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BUPIVACAINE; MELOXICAM

Exclusivity Code : I-933

Exclusivity Expiration Date : 2027-01-23

Application Number : 211988

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

HERON THERAPS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUPIVACAINE; MELOXICAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NP

Exclusivity Expiration Date

2024-05-12

Application Number

211988

Product Number

2

Exclusivity Details

02

HERON THERAPS INC

BUPIVACAINE; MELOXICAM

CPhI India 2024

Not Confirmed

HERON THERAPS INC

U.S.A

CPhI India 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BUPIVACAINE; MELOXICAM

Exclusivity Code : NP

Exclusivity Expiration Date : 2024-05-12

Application Number : 211988

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

HERON THERAPS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUPIVACAINE; MELOXICAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-933

Exclusivity Expiration Date

2027-01-23

Application Number

211988

Product Number

3

Exclusivity Details

03

HERON THERAPS INC

BUPIVACAINE; MELOXICAM

CPhI India 2024

Not Confirmed

HERON THERAPS INC

U.S.A

CPhI India 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BUPIVACAINE; MELOXICAM

Exclusivity Code : I-933

Exclusivity Expiration Date : 2027-01-23

Application Number : 211988

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

HERON THERAPS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUPIVACAINE; MELOXICAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NP

Exclusivity Expiration Date

2024-05-12

Application Number

211988

Product Number

3

Exclusivity Details

04

HERON THERAPS INC

BUPIVACAINE; MELOXICAM

CPhI India 2024

Not Confirmed

HERON THERAPS INC

U.S.A

CPhI India 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BUPIVACAINE; MELOXICAM

Exclusivity Code : NP

Exclusivity Expiration Date : 2024-05-12

Application Number : 211988

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

HERON THERAPS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUPIVACAINE; MELOXICAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-933

Exclusivity Expiration Date

2027-01-23

Application Number

211988

Product Number

1

Exclusivity Details

05

HERON THERAPS INC

BUPIVACAINE; MELOXICAM

CPhI India 2024

Not Confirmed

HERON THERAPS INC

U.S.A

CPhI India 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BUPIVACAINE; MELOXICAM

Exclusivity Code : I-933

Exclusivity Expiration Date : 2027-01-23

Application Number : 211988

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

HERON THERAPS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUPIVACAINE; MELOXICAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NP

Exclusivity Expiration Date

2024-05-12

Application Number

211988

Product Number

1

Exclusivity Details

06

HERON THERAPS INC

BUPIVACAINE; MELOXICAM

CPhI India 2024

Not Confirmed

HERON THERAPS INC

U.S.A

CPhI India 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BUPIVACAINE; MELOXICAM

Exclusivity Code : NP

Exclusivity Expiration Date : 2024-05-12

Application Number : 211988

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

HERON THERAPS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUPIVACAINE; MELOXICAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-933

Exclusivity Expiration Date

2027-01-23

Application Number

211988

Product Number

4

Exclusivity Details

07

HERON THERAPS INC

BUPIVACAINE; MELOXICAM

CPhI India 2024

Not Confirmed

HERON THERAPS INC

U.S.A

CPhI India 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BUPIVACAINE; MELOXICAM

Exclusivity Code : I-933

Exclusivity Expiration Date : 2027-01-23

Application Number : 211988

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

HERON THERAPS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUPIVACAINE; MELOXICAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NP

Exclusivity Expiration Date

2024-05-12

Application Number

211988

Product Number

4

Exclusivity Details

08

HERON THERAPS INC

BUPIVACAINE; MELOXICAM

CPhI India 2024

Not Confirmed

HERON THERAPS INC

U.S.A

CPhI India 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BUPIVACAINE; MELOXICAM

Exclusivity Code : NP

Exclusivity Expiration Date : 2024-05-12

Application Number : 211988

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?